Skip to main content
Equibles

BARCLAYS PLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 312069 LONDON, X0
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,495,849
-$471,846 QoQ
Shares Held
81,429
-19.1% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 215 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. VRDN ranks #95 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in VRDN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,495,849 81,429
2026-03-31 $1,967,695 100,598
2025-12-31 $7,601,774 244,273
2025-09-30 $4,493,947 208,246
2025-06-30 $3,230,833 231,104
2025-03-31 $1,672,369 124,063
2024-12-31 $3,026,175 157,860
2024-09-30 $2,852,781 125,397
2024-06-30 $765,599 58,847
2024-03-31 $2,173,831 124,148
2023-12-31 $4,782,735 219,593
2023-09-30 $2,018,084 131,557
2023-06-30 $6,126,781 257,536
2023-03-31 $2,954,677 116,143
2022-12-31 $2,901,137 99,320
2022-09-30 $13,408,433 653,751
2022-06-30 $211,673 18,295
2022-03-31 $314,330 17,000